CSTL Q4 2020 Earnings — Castle Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CSTLCastle Biosciences, Inc.

$805M

Q4 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$17M-1.9% YoY

Gross Profit

$15M84.5% margin

Operating Income

-$3M-17.5% margin

Net Income

-$5M-28.3% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

+13.7%

Cash Flow

Operating Cash Flow

-$430,000

Free Cash Flow

-$1M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$439M

Total Liabilities

$24M

Stockholders' Equity

$416M

Cash & Equivalents

$410M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$18M	-1.9%
Gross Profit	$15M	$16M	-6.4%
Operating Income	-$3M	$3M	-216.1%
Net Income	-$5M	$2M	-337.9%